A Year In Review
The Microbiome space has seen continued growth with over 1,000 assets now tracked in the beacon database, highlighting continued investment in this emerging field.
The Beacon Microbiome 2024 Landscape Review provides unparalleled insights into the years developments allowing you to be at the forefront of information in the space.
Download Now
Don’t miss out on the latest breakthroughs in Microbiome development!
Dive into the most comprehensive data and insights in the Microbiome space in. Discover the expanding drug pipeline, with over 1,000 assets in development, and gain a deeper understanding of preclinical dominance, clinical trial growth, and investment trends shaping the field.
Stay ahead with key insights into live biotherapeutic products, bacteriophage therapies, and the latest regulatory and funding dynamics.
This Series Includes
The Drug Landscape
A deep dive into the Microbiome assets added to Beacon in 2024, highlighting development phases and key therapeutic targets.
The Trial Landscape
Analysis of new Microbiome trials, including status, success rates, and trial discontinuation insights.
The Commercial Market
A review of Microbiome deals in 2024, analyzing investment value, partnerships, and collaboration.
The Future of the Microbiome Space
Emerging trends in Microbiome drug development, from therapeutic class comparisons to novel approaches.
Regulatory Announcements
Breakdown of Regulatory Updates in the Microbiome landscape
Previous Microbiome Landscape Reviews
Microbiome 2024 H1 Landscape Review
An analysis of the Microbiome landscape in H1 of 2024.
You May Also Be Interested In…
Learn More About Microbiome
- The Most Comprehensive Way to Search the Microbiome Drug Development Landscape: Unique search ontologies based on Microbiome drug and trial characteristics
- Market Leading Approach to Microbiome Preclinical & Clinical Data Curation: Manual curation of key Microbiome research and development data points by Microbiome research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Microbiome company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
